Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-21-175778
Filing Date
2021-05-27
Accepted
2021-05-27 21:52:43
Documents
7
Effectiveness Date
2021-05-27

Document Format Files

Seq Description Document Type Size
1 S-1MEF d123754ds1mef.htm S-1MEF 47568
2 EX-5.1 d123754dex51.htm EX-5.1 41126
3 EX-23.1 d123754dex231.htm EX-23.1 1801
4 EX-23.2 d123754dex232.htm EX-23.2 1806
5 EX-23.3 d123754dex233.htm EX-23.3 1869
6 GRAPHIC g123754g13w08.jpg GRAPHIC 3382
7 GRAPHIC g123754g69r58.jpg GRAPHIC 13536
  Complete submission text file 0001193125-21-175778.txt   118993
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-256581 | Film No.: 21975766
SIC: 2834 Pharmaceutical Preparations